Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Adaptive immune response to Clostridium difficile infection: A perspective for prevention and therapy.

Rees WD, Steiner TS.

Eur J Immunol. 2018 Mar;48(3):398-406. doi: 10.1002/eji.201747295. Epub 2018 Jan 19. Review.

PMID:
29272036
2.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK.

Clin Infect Dis. 2017 Nov 29;65(12):1963-1973. doi: 10.1093/cid/cix959.

PMID:
29194529
3.

Associations of DC-SIGN (CD209) promoter -336G/A polymorphism (rs4804803) with dengue infection: A systematic review and meta-analysis.

Pabalan N, Chaisri S, Tabunhan S, Phumyen A, Jarjanazi H, Steiner TS.

Acta Trop. 2018 Jan;177:186-193. doi: 10.1016/j.actatropica.2017.10.017. Epub 2017 Oct 18. Review.

PMID:
29054571
4.

2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK.

Clin Infect Dis. 2017 Nov 29;65(12):e45-e80. doi: 10.1093/cid/cix669.

PMID:
29053792
5.

Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review.

Manges AR, Steiner TS, Wright AJ.

Infect Dis (Lond). 2016 Aug;48(8):587-92. doi: 10.1080/23744235.2016.1177199. Epub 2016 May 19. Review.

PMID:
27194400
6.

New Insights Into Shiga Toxigenic Escherichia coli Pathogenesis: When Less Is More.

Steiner TS.

J Infect Dis. 2016 Apr 15;213(8):1214-5. doi: 10.1093/infdis/jiv558. Epub 2016 Jan 6. No abstract available.

PMID:
26743844
7.

Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.

Yeung SS, Yeung JK, Lau TT, Forrester LA, Steiner TS, Bowie WR, Bryce EA.

J Clin Pharm Ther. 2015 Dec;40(6):655-60. doi: 10.1111/jcpt.12329. Epub 2015 Nov 7.

PMID:
26547905
8.

Lyme Disease Diagnosed by Alternative Methods: A Phenotype Similar to That of Chronic Fatigue Syndrome.

Patrick DM, Miller RR, Gardy JL, Parker SM, Morshed MG, Steiner TS, Singer J, Shojania K, Tang P; Complex Chronic Disease Study Group.

Clin Infect Dis. 2015 Oct 1;61(7):1084-91. doi: 10.1093/cid/civ470. Epub 2015 Jun 16.

PMID:
26082507
9.

Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.

Yao Y, Vent-Schmidt J, McGeough MD, Wong M, Hoffman HM, Steiner TS, Levings MK.

J Immunol. 2015 Jul 15;195(2):488-97. doi: 10.4049/jimmunol.1403225. Epub 2015 Jun 8.

10.

The worst of both worlds: examining the hypervirulence of the shigatoxigenic/enteroaggregative Escherichia coli O104:H4.

Steiner TS.

J Infect Dis. 2014 Dec 15;210(12):1860-2. doi: 10.1093/infdis/jiu400. Epub 2014 Jul 18. No abstract available.

PMID:
25038259
11.

Meta-analysis in microbiology.

Pabalan N, Jarjanazi H, Steiner TS.

Indian J Med Microbiol. 2014 Jul-Sep;32(3):229-35. doi: 10.4103/0255-0857.136547. Review.

12.

A non-synonymous coding variant (L616F) in the TLR5 gene is potentially associated with Crohn's disease and influences responses to bacterial flagellin.

Sheridan J, Mack DR, Amre DK, Israel DM, Cherkasov A, Li H, Grimard G, Steiner TS.

PLoS One. 2013 Apr 11;8(4):e61326. doi: 10.1371/journal.pone.0061326. Print 2013.

13.

Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.

Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK.

J Immunol. 2013 Mar 1;190(5):2001-8. doi: 10.4049/jimmunol.1201379. Epub 2013 Jan 28.

14.

Enteroaggregative Escherichia coli and acute diarrhea in children: a meta-analysis of South Asian populations.

Pabalan N, Singian E, Jarjanazi H, Steiner TS.

Eur J Clin Microbiol Infect Dis. 2013 May;32(5):597-607. doi: 10.1007/s10096-012-1779-3. Epub 2012 Nov 21.

PMID:
23179250
15.

ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation.

Yao Y, Levings MK, Steiner TS.

Eur J Immunol. 2012 Dec;42(12):3310-21. doi: 10.1002/eji.201142213. Epub 2012 Oct 26.

16.

Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK.

Immunology. 2012 Jun;136(2):115-22. doi: 10.1111/j.1365-2567.2012.03572.x. Review.

17.

Toll-like receptor 5 deficiency protects from wasting disease in a T cell transfer colitis model in T cell receptor-β-deficient mice.

Hardenberg G, Yao Y, Piccirillo CA, Levings MK, Steiner TS.

Inflamm Bowel Dis. 2012 Jan;18(1):85-93. doi: 10.1002/ibd.21738. Epub 2011 Oct 29.

PMID:
22038840
18.

Environmental influences on T regulatory cells in inflammatory bowel disease.

Hardenberg G, Steiner TS, Levings MK.

Semin Immunol. 2011 Apr;23(2):130-8. doi: 10.1016/j.smim.2011.01.012. Epub 2011 Feb 3. Review.

PMID:
21295492
19.

Human CD4+ FOXP3+ regulatory T cells produce CXCL8 and recruit neutrophils.

Himmel ME, Crome SQ, Ivison S, Piccirillo C, Steiner TS, Levings MK.

Eur J Immunol. 2011 Feb;41(2):306-12. doi: 10.1002/eji.201040459. Epub 2011 Jan 11.

20.

The p110α and p110β isoforms of class I phosphatidylinositol 3-kinase are involved in toll-like receptor 5 signaling in epithelial cells.

Ivison SM, Khan MA, Graham NR, Shobab LA, Yao Y, Kifayet A, Sly LM, Steiner TS.

Mediators Inflamm. 2010;2010. pii: 652098. doi: 10.1155/2010/652098. Epub 2010 Oct 3.

Supplemental Content

Loading ...
Support Center